STOCKHOLM, March 11, 2026 /PRNewswire/ -- BioArctic's AB (publ) (STOCKHOLM: BIOA B) partner Eisai announced today that they will present the latest findings on lecanemab at the 2026 International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders (AD/PD™...
Hence then, the article about latest data on long term real world treatment with lecanemab will be presented at the ad pd 2026 congress was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Latest data on long-term, real-world treatment with lecanemab will be presented at the AD/PD™ 2026 congress )
Also on site :
- Bam Adebayo has massive night for Miami Heat, scoring 2nd-most points in a game ever
- How Trump and His Advisers Miscalculated Iran’s Response to War
- 'Pioneer Woman' Ree Drummond's Daughter Alex Shares Gender Reveal for Baby No. 2